购物车
您的购物车当前为空
CT-721 is a potent and time-dependent Bcr-Abl kinase inhibitor with an IC50 of 21.3 nM against wild-type Bcr-Abl kinase and has anti-chronic myeloid leukemia (CML) activity.

CT-721 is a potent and time-dependent Bcr-Abl kinase inhibitor with an IC50 of 21.3 nM against wild-type Bcr-Abl kinase and has anti-chronic myeloid leukemia (CML) activity.
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 25 mg | ¥ 13,900 | 8-10周 | |
| 50 mg | ¥ 18,300 | 8-10周 | |
| 100 mg | ¥ 23,500 | 8-10周 |
| 产品描述 | CT-721 is a potent and time-dependent Bcr-Abl kinase inhibitor with an IC50 of 21.3 nM against wild-type Bcr-Abl kinase and has anti-chronic myeloid leukemia (CML) activity. |
| 靶点活性 | BCR-ABL (WT):21.3 nM |
| 分子量 | 525.04 |
| 分子式 | C30H29ClN6O |
| CAS No. | 1388710-60-8 |
| Smiles | C(NC1=CC(C#CC=2N3C(=NC2)C=CC(Cl)=N3)=C(C)C=C1)(=O)C=4C=C5C([C@H](CC5)N6CCN(C)CC6)=CC4 |
| 密度 | 1.32 g/cm3 (Predicted) |
| 存储 |
对于不同动物的给药剂量换算,您也可以参考 更多